| Literature DB >> 29179885 |
Hsing-Tse Yu1, Hong-Yuan Huang1, Hsiao-Jung Tseng2, Chin-Jung Wang3, Chyi-Long Lee1, Yung-Kuei Soong1.
Abstract
BACKGROUND: To assess whether the unilateral or bilateral lesions can affect ovarian reserve and pregnancy outcome in in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) in infertility patients underwent laparoscopic cystectomy.Entities:
Keywords: Bilaterality; Endometrioma; Intracytoplasmic sperm injection; In vitro fertilization; Laparoscopy
Mesh:
Year: 2017 PMID: 29179885 PMCID: PMC6138598 DOI: 10.1016/j.bj.2017.06.009
Source DB: PubMed Journal: Biomed J ISSN: 2319-4170 Impact factor: 4.910
Patient characteristics.
| Unilateral side | Bilateral sides | ||
|---|---|---|---|
| Cycles | 103 | 45 | |
| Age (years) | 34.2 ± 3.9 | 33.3 ± 4.3 | NS |
| BMI (kg/m2) | 21.4 ± 3.2 | 20.5 ± 2.2 | NS |
| Infertility duration (years) | 4.5 ± 2.7 | 4.0 ± 2.9 | NS |
| CA125 before operation (U/mL) | 97.6 ± 193.3 | 119.7 ± 121.3 | NS |
| Size of dominant endometrioma during operation (cm) | 5.0 ± 2.0 | 5.3 ± 1.4 | NS |
| Operation time (min) | 98.7 ± 46.6 | 116.5 ± 29.7 | 0.034 |
| rAFS score | 41.0 ± 23.8 | 64.8 ± 27.9 | <0.001 |
Abbreviations: BMI: body mass index; CA125: cancer antigen 125; rAFS: revised classification of the American Fertility Society; NS: non-significant.
Significant at p < 0.05. values are given as mean ± SD or number.
Baseline characteristics and responses after controlled ovarian hyperstimulation of study participants.
| Unilateral side | Bilateral sides | ||
|---|---|---|---|
| Day 2 or day 3 FSH (mIU/mL) | 7.9 ± 2.9 (7.9; 1.6–15.4) | 10.1 ± 7.2 (8.4; 2.5–32.1) | NS |
| Day 2 or day 3 E2 (pg/mL) | 40.1 ± 37.9 (27; 10–188) | 29.1 ± 25.2 (23.5; 2.1–100) | NS |
| Antral follicle count | 7.3 ± 4.4 (6; 0–21) | 7.0 ± 4.2 (6; 2–23) | NS |
| FSH dosage (IU) | 2387.9 ± 1054.6 (2175; 800–9090) | 2130.5 ± 1035.6 (1900; 700–5400) | NS |
| Number of days of stimulation | 10.0 ± 1.5 (10; 7–14) | 10.0 ± 2.0 (10; 7–17) | NS |
| No. of follicles >1.4 cm on hCG day | 5.2 ± 3.1 (5; 1–15) | 4.2 ± 2.7 (4; 0–12) | 0.048 |
| Endometrium thickness on hCG day (cm) | 1.1 ± 0.2 (1.0; 0.6–1.9) | 1.1 ± 0.3 (1.1; 0.6–1.55) | NS |
| Peak E2 level (pg/mL) | 1692.8 ± 1199.5 (1305; 259–5008) | 1473.4 ± 1532.1 (1241; 95–9998) | NS |
Abbreviations: FSH: follicle-stimulating hormone; E2: estradiol; hCG: human chorionic gonadotrophin; NS: non-significant.
Significant at p < 0.05. values are given as mean ± SD or number (median; range).
Fertility and reproductive outcomes after in vitro fertilization/intracytoplasmic sperm injection.
| Unilateral side | Bilateral sides | ||
|---|---|---|---|
| No. of oocytes retrieved | 10.0 ± 6.9 (8; 1–33) | 7.6 ± 6.6 (5; 0–39) | 0.047 |
| MII oocytes | 7.2 ± 5.1 | 6.1 ± 4.6 | NS |
| Proportion of MII oocytes (%) | 75.2 ± 24.3 | 78.3 ± 21.9 | NS |
| Normal fertilization rate (%) | 64.9 ± 23.6 | 65.9 ± 22.6 | NS |
| No. of embryos transferred | 2.9 ± 1.4 | 2.4 ± 1.4 | 0.020 |
| Cryopreservation for surplus embryos (%) | 20.4 | 17.8 | NS |
| No. of cleavage stage embryo transfer (%) | 93 (90.3) | 45 (100) | 0.032 |
| Good-quality embryos for transfer (%) | 64.7 | 65.1 | NS |
| Implantation rate (%) | 13.6 | 20.8 | NS |
| Clinical pregnancy rate per cycle (%) | 33.3 | 33.3 | NS |
| Live-born rate per cycle (%) | 19.4 | 22.2 | NS |
Abbreviations: MII: mature; NS: non-significant.
Significant at p < 0.05. values are given as mean ± SD or % (median; range).
Good-quality embryos are defined as grade 1 or 2 embryos.